Cargando…
Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19
BACKGROUND: Evidence-based therapies used to treat coronavirus disease (COVID-19) remain limited. Azoximer bromide (AZB; Polyoxidonium(®)) is an immunomodulating molecule frequently used in the Russian Federation. It offers demonstrable therapeutic benefit in upper respiratory tract infections. This...
Autores principales: | Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Luydmila Yu, Kuntsevich, Elena V, Troshina, Anastasia A, Kvasova, Elena I, Tikhonov, Anton A, Khomyakova, Nadezhda F, Harrison, Francisco, Rossi, Jean-François, Hardman, Timothy C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903879/ https://www.ncbi.nlm.nih.gov/pubmed/35310299 http://dx.doi.org/10.7573/dic.2022-1-1 |
Ejemplares similares
-
The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
por: Efimov, Sergey V, et al.
Publicado: (2021) -
The Mechanism of Dedoping PEDOT:PSS by Aliphatic Polyamines
por: van der Pol, Tom P. A., et al.
Publicado: (2019) -
Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro.
por: Kalashnikov, Sergey V, et al.
Publicado: (2002) -
Polyamine import and accumulation causes immunomodulation in macrophages engulfing apoptotic cells
por: McCubbrey, Alexandra L., et al.
Publicado: (2022) -
Glutathione reactivity with aliphatic polyisocyanates
por: Wisnewski, Adam V., et al.
Publicado: (2022)